SEARCH

SEARCH BY CITATION

References

  • 1
    Muroi E, Hara T, Yanaba K et al. A portable dermatoscope for easy, rapid examination of periungual nailfold capillary changes in patients with systemic sclerosis. Rheumatol Int 2011; 31: 16016.
  • 2
    Moore TL, Roberts C, Murray AK et al. Reliability of dermoscopy in the assessment of patients with Raynaudís phenomenon. Rheumatology 2010; 49: 5427.
  • 3
    Sander O, Iking-Konert C, Ostendorf B. Taschenatlas Kapillarmikroskopie. Georg Thieme Verlag, Stuttgart, 2007.
  • 4
    Hirschl M, Hirschl K, Lenz M et al. Transition from primary Raynaudís phenomenon to secondary Raynaudís phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance. Arthritis Rheum 2006; 54: 197481.
  • 5
    Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998; 158: 595600.
  • 6
    Meli M, Gitzelmann G, Koppensteiner R, Amann-Vesti BR. Predictive value of nailfold capillaroscopy in patients with Raynaudís phenomenon. Clin Rheumatol 2006; 25: 1538.
  • 7
    Cutolo M, Pizzorni C, Tuccio M et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004; 43: 71926.
  • 8
    Sulli A, Secchi ME, Pizzorni C, Cutolo M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008; 67: 8857.
  • 9
    Sander O, Sunderkötter C, Kötter I et al. Capillaroscopy. Procedure and nomenclature. Z Rheumatol 2010; 69: 25362.
  • 10
    Koenig M, Joyal F, Fritzler MJ et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaudís phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008; 58: 390212.
  • 11
    Ingegnoli F, Boracchi P, Gualtierotti R et al. Prognostic model based on nailfold capillaroscopy for identifying Raynaudís phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination). Arthritis Rheum 2008; 58: 217482.
  • 12
    Sebastiani M, Manfredi A, Colaci M et al. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 2009; 61: 68894.
  • 13
    Sebastiani M, Manfredi A, Vukatana G et al. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 2012; 71: 6770.
  • 14
    Ingegnoli F, Boracchi P, Gualtierotti R et al. Improving outcome prediction of systemic sclerosis from isolated Raynaudís phenomenon: role of autoantibodies and nail-fold capillaroscopy. Rheumatology 2010; 49: 797805.
  • 15
    Hoerth C, Kundi M, Katzenschlager R, Hirschl M. Qualitative and quantitative assessment of nailfold capillaries by capillaroscopy in healthy volunteers. Vasa 2012; 41: 1926.
  • 16
    Avouac J, Fransen J, Walker UA et al. EUSTAR Group. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011; 70: 47681.
  • 17
    Chen ZY, Silver RM, Ainsworth SK et al. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med. 1984; 77: 81222.
  • 18
    Caramaschi P, Canestrini S, Martinelli N et al. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Reumatology 2007; 46: 15669.
  • 19
    Hofstee HM, Vonk Noordegraaf A, Voskuyl AE et al. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 2009; 68: 1915.
  • 20
    De Angelis R, Cutolo M, Gutierrez M et al. Different microvascular involvement in dermatomyositis and systemic sclerosis. A preliminary study by a tight videocapillaroscopic assessment. Clin Exp Rheumatol 2012; 30: S6770.
  • 21
    Lambova SN, Mller-Ladner U. Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: What we still have to learn? Rheumatol Int 2013; 33(3): 68995.
  • 22
    Pavlov-Dolijanovic S, Damjanov NS, Vujasinovic Stupar NZ et al. Is there a difference in systemic lupus erythematosus with and without Raynaudís phenomenon? Ann Rheum Dis 2012; 71: 16369.
  • 23
    Capobianco KG, Xavier RM, Bredemeier M et al. Nailfold capillaroscopic findings in primary Sjögrenís syndrome: clinical and serological correlations. Clin Exp Rheumatol 2005; 23: 78994.